Pharmacyclics, Inc. (PCYC) Posts Wider than Expected Q4 Loss

Pharmacyclics, Inc. (NASDAQ: PCYC) reported Q4 non-GAAP loss of ($0.15), versus the analyst estimate of ($0.14). Revenue for the quarter came in at $1.39 million versus the consensus estimate of $2.67 million.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c